MAWCM
PFE icon

Mine & Arao Wealth Creation & Management’s Pfizer PFE Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
9,035
+96
+1% +$2.51K 0.08% 75
2026
Q1 		$251K Buy
8,939
+94
+1% +$2.5K 0.11% 72
2025
Q4 		$220K Buy
8,845
+94
+1% +$2.37K 0.09% 74
2025
Q3 		$223K Sell
8,751
-139
-2% -$3.43K 0.09% 71
2025
Q2 		$215K Sell
8,890
-71
-0.8% -$1.66K 0.1% 72
2025
Q1 		$227K Buy
8,961
+92
+1% +$2.41K 0.11% 67
2024
Q4 		$235K Buy
8,869
+1,844
+26% +$50K 0.11% 67
2024
Q3 		$203K Buy
+7,025
New +$205K 0.09% 75
2024
Q2 		– Sell
-8,058
Closed -$224K – 276
2024
Q1 		$224K Sell
8,058
-387
-5% -$10.7K 0.11% 69
2023
Q4 		$243K Buy
8,445
+1,507
+22% +$45.6K 0.13% 68
2023
Q3 		$230K Sell
6,938
-237
-3% -$8.38K 0.14% 62
2023
Q2 		$263K Sell
7,175
-14,403
-67% -$561K 0.15% 62
2023
Q1 		$880K Buy
21,578
+4,666
+28% +$202K 0.57% 25
2022
Q4 		$867K Sell
16,912
-6,729
-28% -$323K 0.64% 25
2022
Q3 		$1.03M Buy
23,641
+70
+0.3% +$3.4K 0.76% 19
2022
Q2 		$1.24M Buy
23,571
+36
+0.2% +$1.83K 0.87% 17
2022
Q1 		$1.22M Buy
23,535
+113
+0.5% +$5.86K 0.71% 22
2021
Q4 		$1.38M Buy
23,422
+10
+0% +$495 0.76% 20
2021
Q3 		$1.01M Sell
23,412
-90
-0.4% -$3.99K 0.6% 24
2021
Q2 		$920K Buy
23,502
+27
+0.1% +$1.05K 0.56% 26
2021
Q1 		$850K Buy
23,475
+152
+0.7% +$5.4K 0.57% 28
2020
Q4 		$858K Buy
23,323
+9,506
+69% +$349K 0.62% 26
2020
Q3 		$481K Buy
13,817
+755
+6% +$26.5K 0.4% 36
2020
Q2 		$405K Buy
13,062
+94
+0.7% +$3.19K 0.38% 37
2020
Q1 		$402K Sell
12,968
-1,132
-8% -$38.6K 0.47% 34
2019
Q4 		$524K Buy
+14,100
New +$502K 0.49% 32

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's PFE Position: Q2 2026 in Review

Mine & Arao Wealth Creation & Management increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $2.51K and bringing the position to 9,035 shares worth $218K. The position accounts for 0.08% of the portfolio, ranked #75.

Mine & Arao Wealth Creation & Management first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.38M in Q4 2021. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mine & Arao Wealth Creation & Management held 9,035 shares of Pfizer worth $218K as of Q2 2026.
  • Mine & Arao Wealth Creation & Management bought 96 Pfizer shares in Q2 2026, an estimated $2.51K.
  • Pfizer made up 0.08% of Mine & Arao Wealth Creation & Management's portfolio in Q2 2026, its #75 holding.
  • Mine & Arao Wealth Creation & Management first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Mine & Arao Wealth Creation & Management's Pfizer position peaked at $1.38M in Q4 2021.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2026, filed 23 Jul 2026.